Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

NCT00993720 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Liraglutide
DRUG: Liraglutide
OTHER: continuous insulin therapy

Sponsor

Hvidovre University Hospital